Urothelial-type adenocarcinoma of the prostate mimicking metastatic colorectal adenocarcinoma

International Braz J Urol

Volumn 32, Issue 6, 2006, Pages 681-687

  Adley, Brian P ^a   Maxwell, Kelly ^a   Dalton, Daniel P ^a   Yang, Ximing J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Pathology; Prostate; Urothelial type adenocarcinoma

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7; PROSTATE SPECIFIC ANTIGEN; TRANSCRIPTION FACTOR CDX2;

ADENOCARCINOMA; ADULT; ANAMNESIS; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CASE REPORT; COLONOSCOPY; COLORECTAL CARCINOMA; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; METASTASIS; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATECTOMY;

EID: 33846452138     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/s1677-55382006000600009     Document Type: Article

References (15)

1. Tran KP, Epstein JI: Mucinous adenocarcinoma of urinary bladder type arising from the prostatic urethra. Distinction from mucinous adenocarcinoma of the prostate. Am J Surg Pathol. 1996; 20: 1346-50.
2. Curtis MW, Evans AJ, Srigley JR: Mucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging entity. Mod Pathol. 2005; 18: 585-90.
3. Malpica A, Ro JY, Troncoso P, Ordonez NG, Amin MB, Ayala AG: Nephrogenic adenoma of the prostatic urethra involving the prostate gland: a clinicopathologic and immunohistochemical study of eight cases. Hum Pathol. 1994; 25: 390-5.
4. Nicolaisen GS, Williams RD: Primary transitional cell carcinoma of prostate. Urology. 1984; 24: 544-9.
5. Sawczuk I, Tannenbaum M, Olsson CA, deVere White R: Primary transitional cell carcinoma of prostatic periurethral ducts. Urology. 1985; 25: 339-43.
6. Grignon DJ, Ro JY, Ayala AG, Johnson DE, Ordonez NG: Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases. Cancer. 1991; 67: 2165-72.
7. Wang HL, Lu DW, Yerian LM, Alsikafi N, Steinberg G, Hart J, et al.: Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol. 2001; 25: 1380-7.
8. Epstein JI, Lieberman PH: Mucinous adenocarcinoma of the prostate gland. Am J Surg Pathol. 1985; 9: 299-308.
9. Christensen WN, Steinberg G, Walsh PC, Epstein JI: Prostatic duct adenocarcinoma. Findings at radical prostatectomy. Cancer. 1991; 67: 2118-24.
10. Wang NP, Zee S, Zarbo RJ, Bacchi CE, Gown AM: Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 1995; 3: 99-107.
11. Tamboli P, Mohsin SK, Hailemariam S, Amin MB: Colonic adenocarcinoma metastatic to the urinary tract versus primary tumors of the urinary tract with glandular differentiation: a report of 7 cases and investigation using a limited immunohistochemical panel. Arch Pathol Lab Med. 2002; 126: 1057-63.
12. Yang XJ, Lecksell K, Gaudin P, Epstein JI: Rare expression of high-molecular-weight cytokeratin in adenocarcinoma of the prostate gland: a study of 100 cases of metastatic and locally advanced prostate cancer. Am J Surg Pathol. 1999; 23: 147-52.
13. Xu J, Stolk JA, Zhang X, Silva SJ, Houghton RL, Matsumura M, et al.: Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res. 2000; 60: 1677-82.
14. Jiang Z, Fanger GR, Banner BF, Woda BA, Algate P, Dresser K, et al.: A dietary enzyme: alpha-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma. Cancer Detect Prev. 2003; 27: 422-6.
15. Suh N, Yang XJ, Tretiakova MS, Humphrey PA, Wang HL: Value of CDX2, villin, and alpha-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Mod Pathol. 2005; 18: 1217-22.